Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMC 3147913)

Published in J Virol on May 18, 2011

Authors

Joshua T Herbeck1, Morgane Rolland, Yi Liu, Sherry McLaughlin, John McNevin, Hong Zhao, Kim Wong, Julia N Stoddard, Dana Raugi, Stephanie Sorensen, Indira Genowati, Brian Birditt, Angela McKay, Kurt Diem, Brandon S Maust, Wenjie Deng, Ann C Collier, Joanne D Stekler, M Juliana McElrath, James I Mullins

Author Affiliations

1: Department of Microbiology, SC-42, University of Washington School of Medicine, Seattle, WA 98195-8070, USA.

Articles citing this

HIV-1 persistence in CD4+ T cells with stem cell-like properties. Nat Med (2014) 2.30

Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression. AIDS (2013) 2.04

De novo assembly of highly diverse viral populations. BMC Genomics (2012) 1.87

Specific capture and whole-genome sequencing of viruses from clinical samples. PLoS One (2011) 1.78

New insights into the evolutionary rate of HIV-1 at the within-host and epidemiological levels. Proc Biol Sci (2012) 1.43

Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection. PLoS Pathog (2017) 1.38

Within-host and between-host evolutionary rates across the HIV-1 genome. Retrovirology (2013) 1.21

The genealogical population dynamics of HIV-1 in a large transmission chain: bridging within and among host evolutionary rates. PLoS Comput Biol (2014) 1.18

Sieve analysis in HIV-1 vaccine efficacy trials. Curr Opin HIV AIDS (2013) 1.07

Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial. J Virol (2014) 1.03

An integrated map of HIV genome-wide variation from a population perspective. Retrovirology (2015) 0.93

Indel and Carryforward Correction (ICC): a new analysis approach for processing 454 pyrosequencing data. Bioinformatics (2013) 0.92

Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus. PLoS Pathog (2016) 0.90

Immune-mediated attenuation of HIV-1. Future Virol (2011) 0.89

Structured observations reveal slow HIV-1 CTL escape. PLoS Genet (2015) 0.88

Tracking the Emergence of Host-Specific Simian Immunodeficiency Virus env and nef Populations Reveals nef Early Adaptation and Convergent Evolution in Brain of Naturally Progressing Rhesus Macaques. J Virol (2015) 0.86

New insights into the evolutionary rate of hepatitis B virus at different biological scales. J Virol (2015) 0.85

Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgrounds. PLoS One (2014) 0.85

Increased sequence coverage through combined targeting of variant and conserved epitopes correlates with control of HIV replication. J Virol (2013) 0.85

Viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary HIV-1 subtype C infection. PLoS One (2012) 0.84

Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection. PLoS One (2012) 0.80

Evaluating Clonal Expansion of HIV-Infected Cells: Optimization of PCR Strategies to Predict Clonality. PLoS Pathog (2016) 0.79

Quality score based identification and correction of pyrosequencing errors. PLoS One (2013) 0.79

Early immune adaptation in HIV-1 revealed by population-level approaches. Retrovirology (2014) 0.79

Breast milk and in utero transmission of HIV-1 select for envelope variants with unique molecular signatures. Retrovirology (2017) 0.79

An evaluation of phylogenetic methods for reconstructing transmitted HIV variants using longitudinal clonal HIV sequence data. J Virol (2014) 0.78

Effect of the Latent Reservoir on the Evolution of HIV at the Within- and Between-Host Levels. PLoS Comput Biol (2017) 0.77

Stable multi-infection of splenocytes during SIV infection--the basis for continuous recombination. Retrovirology (2012) 0.77

Large Variations in HIV-1 Viral Load Explained by Shifting-Mosaic Metapopulation Dynamics. PLoS Biol (2016) 0.76

Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5∆32/∆32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction. Sci Rep (2015) 0.76

Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection. J Virol (2015) 0.76

Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early Infection. AIDS Res Hum Retroviruses (2016) 0.75

Short-Sighted Virus Evolution and a Germline Hypothesis for Chronic Viral Infections. Trends Microbiol (2017) 0.75

Ineffectual targeting of HIV-1 Nef by cytotoxic T lymphocytes in acute infection results in no functional impairment or viremia reduction. J Virol (2014) 0.75

Genotypic and phenotypic heterogeneity in the U3R region of HIV type 1 subtype C. AIDS Res Hum Retroviruses (2013) 0.75

The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards. Sci Rep (2017) 0.75

Accurate quantification of within- and between-host HBV evolutionary rates requires explicit transmission chain modelling. Virus Evol (2017) 0.75

Articles cited by this

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47

A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol (2003) 102.57

Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics (1989) 73.50

Statistical tests of neutrality of mutations. Genetics (1993) 24.94

A test of neutral molecular evolution based on nucleotide data. Genetics (1987) 24.44

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol (1994) 22.96

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science (1996) 18.38

HyPhy: hypothesis testing using phylogenies. Bioinformatics (2004) 17.33

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A (2008) 16.54

Pairwise comparisons of mitochondrial DNA sequences in stable and exponentially growing populations. Genetics (1991) 16.12

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol (1994) 15.93

DnaSP version 3: an integrated program for molecular population genetics and molecular evolution analysis. Bioinformatics (1999) 14.86

Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science (1993) 13.87

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (2003) 11.66

Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol (1999) 10.41

Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30

Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol (2008) 7.54

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med (2009) 7.01

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med (1995) 6.90

HIV-1 transmission, by stage of infection. J Infect Dis (2008) 6.57

Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med (2009) 6.22

Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci (2003) 5.94

Biological and virologic characteristics of primary HIV infection. Ann Intern Med (1998) 5.45

HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology (1992) 4.70

Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science (2007) 4.60

Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol (2003) 4.56

Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol (2009) 4.40

Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol (2005) 4.38

Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol (1994) 4.35

Adaptation of HIV-1 to human leukocyte antigen class I. Nature (2009) 4.24

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med (1997) 4.21

Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog (2009) 4.04

Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology (2004) 3.98

Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis (2000) 3.73

High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog (2010) 3.68

Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature (1995) 3.61

Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens (2003) 2.93

Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1. J Virol (2004) 2.91

Pervasive genomic recombination of HIV-1 in vivo. Genetics (2004) 2.79

Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J Virol (2008) 2.72

Virus population homogenization following acute human immunodeficiency virus type 1 infection. J Virol (2002) 2.71

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med (2011) 2.71

Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. J Virol (2006) 2.70

Wide variation in the multiplicity of HIV-1 infection among injection drug users. J Virol (2010) 2.67

Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA (2007) 2.59

Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. J Virol (2008) 2.56

Selection on the human immunodeficiency virus type 1 proteome following primary infection. J Virol (2006) 2.48

Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog (2009) 2.36

Modeling sequence evolution in acute HIV-1 infection. J Theor Biol (2009) 2.32

HIV-1 group M conserved elements vaccine. PLoS Pathog (2007) 2.28

Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J Virol (1998) 2.21

HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLoS Pathog (2009) 2.15

Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog (2009) 2.10

Leveraging information across HLA alleles/supertypes improves epitope prediction. J Comput Biol (2007) 2.03

Human immunodeficiency virus type 1 populations in blood and semen. J Virol (1998) 1.99

Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes. J Virol Methods (2006) 1.99

Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. J Virol (2006) 1.82

Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J Virol (2010) 1.82

HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study. J Infect Dis (2008) 1.70

Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection. AIDS (2002) 1.70

Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). Tissue Antigens (1995) 1.59

Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med (1997) 1.52

Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. J Virol (2005) 1.52

Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics. PLoS Pathog (2009) 1.49

HIV-1 Populations in Semen Arise through Multiple Mechanisms. PLoS Pathog (2010) 1.47

Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populations. J Virol Methods (2010) 1.38

Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape. J Virol (2007) 1.35

Male genital tract compartmentalization of human immunodeficiency virus type 1 (HIV). AIDS Res Hum Retroviruses (2008) 1.18

HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection. J Virol (2008) 1.13

Human immunodeficiency virus type 1 molecular evolution and the measure of selection. AIDS Res Hum Retroviruses (1996) 1.11

Evolution of pathogenic viruses with special reference to the rates of synonymous and nonsynonymous substitutions. Jpn J Genet (1994) 0.96

HIV-1 in semen: an isolated virus reservoir. Lancet (1997) 0.95

HIV type 1 V3 sequence diversity in contact-traced Swedish couples at the time of sexual transmission. AIDS Res Hum Retroviruses (1994) 0.91

The relationship between AIDS and immunologic tolerance. J Acquir Immune Defic Syndr (1992) 0.77

Articles by these authors

ABySS: a parallel assembler for short read sequence data. Genome Res (2009) 43.20

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med (2002) 24.07

Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet (2008) 19.65

Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol (2008) 15.90

Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med (2012) 12.98

Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med (2004) 12.20

Stromal gene expression predicts clinical outcome in breast cancer. Nat Med (2008) 10.68

Mouse genomic variation and its effect on phenotypes and gene regulation. Nature (2011) 10.66

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med (2006) 10.34

Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med (2002) 9.70

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature (2010) 8.78

A loss-of-function RNA interference screen for molecular targets in cancer. Nature (2006) 8.11

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56

Oncogenically active MYD88 mutations in human lymphoma. Nature (2010) 7.34

Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell (2007) 7.10

Novel, acentric metal-organic coordination polymers from hydrothermal reactions involving in situ ligand synthesis. Angew Chem Int Ed Engl (2002) 7.04

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol (2008) 6.91

XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity (2004) 6.72

KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (2003) 6.60

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science (2008) 6.52

Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity (2007) 6.36

Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol (2006) 6.30

IRF4 addiction in multiple myeloma. Nature (2008) 6.27

Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity (2002) 6.27

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell (2003) 6.11

Molecular diagnosis of Burkitt's lymphoma. N Engl J Med (2006) 6.10

Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science (2009) 6.07

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med (2003) 6.06

The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature (2012) 5.61

The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell (2008) 5.58

Towards an HIV cure: a global scientific strategy. Nat Rev Immunol (2012) 5.52

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J Virol (2006) 5.41

Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med (2011) 5.21

The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS (2007) 5.18

HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol (2008) 5.01

Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A (2006) 4.90

Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis (2008) 4.86

mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science (2010) 4.81

Attenuated cold sensitivity in TRPM8 null mice. Neuron (2007) 4.73

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination. J Immunol Methods (2007) 4.69

Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science (2007) 4.60

Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science (2005) 4.58

Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol (2003) 4.56

Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature (2007) 4.54

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy. N Engl J Med (2009) 4.54

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet (2011) 4.38

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature (2012) 4.33

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1. Ann Intern Med (2011) 4.21

A framework for assessing immunological correlates of protection in vaccine trials. J Infect Dis (2007) 3.95

Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLoS One (2006) 3.91

White Collar-1, a circadian blue light photoreceptor, binding to the frequency promoter. Science (2002) 3.85

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Nature (2012) 3.83

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK. Proc Natl Acad Sci U S A (2006) 3.83

Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet (2013) 3.83

Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J Virol (2007) 3.78

Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J Clin Invest (2005) 3.62

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus. J Infect Dis (2007) 3.50

Synthesis of novel chiral and acentric coordination polymers by the reaction of zinc or cadmium salts with racemic 3-pyridyl-3-aminopropionic acid. Chemistry (2004) 3.49

Sequence-based characterization of structural variation in the mouse genome. Nature (2011) 3.48

Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity (2006) 3.41

Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature (2010) 3.39

Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J Immunol Methods (2007) 3.29

A Blueprint for HIV Vaccine Discovery. Cell Host Microbe (2012) 3.27

Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor. Nat Med (2010) 3.26

Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS (2010) 3.26

Setting the stage: host invasion by HIV. Nat Rev Immunol (2008) 3.25

R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6. Proc Natl Acad Sci U S A (2007) 3.24

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. N Engl J Med (2013) 3.24

Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol (2005) 3.23

High-throughput in vivo analysis of gene expression in Caenorhabditis elegans. PLoS Biol (2007) 3.22

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood (2003) 3.16

The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors. Nat Chem Biol (2010) 3.15

Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell (2012) 3.00

Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. J Infect Dis (2003) 2.98

White collar-1, a DNA binding transcription factor and a light sensor. Science (2002) 2.97

Allosteric inhibitors of Bcr-abl-dependent cell proliferation. Nat Chem Biol (2006) 2.96

Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J Endod (2008) 2.95

Practical reconstruction method for bioluminescence tomography. Opt Express (2005) 2.83

Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus. J Virol (2005) 2.82

Pervasive genomic recombination of HIV-1 in vivo. Genetics (2004) 2.79

Replacing clinic-based tests with home-use tests may increase HIV prevalence among Seattle men who have sex with men: evidence from a mathematical model. Sex Transm Dis (2014) 2.79

Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J Virol (2008) 2.72

Highly stable olefin-Cu(I) coordination oligomers and polymers. Chem Soc Rev (2005) 2.72

Virus population homogenization following acute human immunodeficiency virus type 1 infection. J Virol (2002) 2.71

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med (2011) 2.71